Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 6.45%198M | 26.55%224M | 74.19%-16M | 281.31%408M | 694.44%107M | 43.08%186M | 39.37%177M | 53.03%-62M | -58.04%107M | 40.00%-18M |
| Net income from continuing operations | 10.00%88M | -3.64%106M | 20.78%93M | -2.15%319M | -7.14%52M | -27.27%80M | 10.00%110M | 28.33%77M | 35.27%326M | 55.56%56M |
| Depreciation and amortization | 12.50%36M | 6.25%34M | 12.50%36M | 19.27%130M | 9.68%34M | 18.52%32M | 23.08%32M | 28.00%32M | 22.47%109M | 19.23%31M |
| Deferred tax | 7.41%29M | -7.89%35M | 20.00%30M | -8.57%96M | -50.00%6M | -30.77%27M | 15.15%38M | 19.05%25M | 23.53%105M | -14.29%12M |
| Other non cashItems | -35.71%18M | 5.88%18M | -188.00%-22M | 16.46%92M | -21.43%22M | 75.00%28M | -10.53%17M | 56.25%25M | 88.10%79M | 55.56%28M |
| Change In working capital | 26.98%80M | 200.00%87M | 34.72%-126M | 83.48%-57M | 139.64%44M | 431.58%63M | 70.59%29M | 16.81%-193M | -228.57%-345M | -13.27%-111M |
| -Change in receivables | -80.00%14M | -9.09%-48M | 18.09%-77M | 722.22%56M | 39.33%124M | 180.00%70M | -120.00%-44M | 8.74%-94M | 79.07%-9M | 154.29%89M |
| -Change in inventory | 162.96%71M | 86.84%142M | 64.96%-41M | 76.77%-82M | 64.21%-68M | 156.25%27M | 230.43%76M | 15.22%-117M | -370.67%-353M | -39.71%-190M |
| -Change in payables and accrued expense | 88.24%-4M | --0 | -200.00%-11M | -544.44%-40M | 6.90%-27M | -780.00%-34M | -54.55%10M | 0.00%11M | -59.09%9M | -107.14%-29M |
| -Change in other current assets | ---1M | 46.15%-7M | -57.14%3M | 12.50%9M | -21.05%15M | --0 | -62.50%-13M | 450.00%7M | 188.89%8M | 11.76%19M |
| Interest paid (cash flow from operating activities) | 8.00%-23M | 55.00%-9M | -13.64%-25M | -25.00%-85M | 0.00%-18M | -19.05%-25M | -42.86%-20M | -46.67%-22M | -112.50%-68M | -100.00%-18M |
| Tax refund paid | -57.89%-30M | -62.07%-47M | 66.67%-2M | 12.12%-87M | -106.25%-33M | 13.64%-19M | 46.30%-29M | 14.29%-6M | -52.31%-99M | 5.88%-16M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 6.45%198M | 26.55%224M | 74.19%-16M | 281.31%408M | 694.44%107M | 43.08%186M | 39.37%177M | 53.03%-62M | -58.04%107M | 40.00%-18M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 28.57%-30M | -48.57%-52M | -46.67%-22M | 46.90%-137M | 28.57%-45M | 56.25%-42M | 37.50%-35M | 65.12%-15M | -67.53%-258M | 22.22%-63M |
| Net PPE purchase and sale | 45.71%-19M | -3.03%-34M | 13.04%-20M | 14.84%-132M | 21.15%-41M | 16.67%-35M | 0.00%-33M | 17.86%-23M | -59.79%-155M | -30.00%-52M |
| Net intangibles purchas and sale | 33.33%-2M | 0.00%-2M | 0.00%-2M | -10.00%-11M | -33.33%-4M | -50.00%-3M | 33.33%-2M | 0.00%-2M | 9.09%-10M | 0.00%-3M |
| Net business purchase and sale | -150.00%-10M | ---48M | ---- | 95.70%-4M | --0 | 92.31%-4M | --0 | --0 | -102.17%-93M | 78.95%-8M |
| Net other investing changes | --1M | --32M | ---- | --10M | --0 | ---- | ---- | --10M | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 28.57%-30M | -48.57%-52M | -46.67%-22M | 46.90%-137M | 28.57%-45M | 56.25%-42M | 37.50%-35M | 65.12%-15M | -67.53%-258M | 22.22%-63M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -13.89%-164M | -32.39%-188M | -10.39%69M | -246.36%-221M | -114.81%-12M | -323.53%-144M | -100.00%-142M | -56.00%77M | 249.50%151M | -27.03%81M |
| Net issuance payments of debt | -28.00%-128M | -48.89%-134M | -8.70%84M | -119.77%-68M | -76.92%30M | -534.78%-100M | -500.00%-90M | -55.34%92M | 168.75%344M | -19.75%130M |
| Net common stock issuance | 33.33%-20M | 0.00%-20M | 0.00%-15M | 36.62%-90M | 32.43%-25M | 33.33%-30M | 33.33%-20M | 50.00%-15M | 21.11%-142M | 2.63%-37M |
| Cash dividends paid | -13.33%-17M | -6.25%-34M | ---- | -18.87%-63M | -23.08%-16M | -15.38%-15M | -18.52%-32M | ---- | -8.16%-53M | -8.33%-13M |
| Net other financing activities | 0.00%1M | ---- | ---- | ---- | ---- | 0.00%1M | ---- | ---- | --2M | --1M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -13.89%-164M | -32.39%-188M | -10.39%69M | -246.36%-221M | -114.81%-12M | -323.53%-144M | -100.00%-142M | -56.00%77M | 249.50%151M | -27.03%81M |
| Net cash flow | ||||||||||
| Beginning cash position | --65M | --81M | --50M | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Current changes in cash | --4M | ---16M | --31M | --50M | ---- | ---- | ---- | ---- | ---- | ---- |
| End cash Position | --69M | --65M | --81M | --50M | --50M | --0 | --0 | --0 | --0 | --0 |
| Free cash from | 19.59%177M | 32.39%188M | 56.32%-38M | 556.90%265M | 184.93%62M | 72.09%148M | 56.04%142M | 46.30%-87M | -139.46%-58M | 0.00%-73M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.